Gilead (GILD) Gains 16.8% in 3 Months: How Should You Play the Stock?Zacks Investment Research • 08/26/24
Gilead Sciences alleges dangerous drug-counterfeiting operation at two NYC pharmacies in lawsuitCNBC • 08/16/24
Gilead's Livdelzi (Seladelpar) Granted Accelerated Approval for Primary Biliary Cholangitis by U.S. FDABusiness Wire • 08/14/24
Analysts Cite Improved Investor Sentiment For Gilead, But Warn of Limited Growth at Current Stock LevelsBenzinga • 08/09/24
Countdown to Gilead (GILD) Q2 Earnings: Wall Street Forecasts for Key MetricsZacks Investment Research • 08/05/24
Should You Buy, Sell or Hold Gilead Sciences (GILD) Before Q2 Earnings?Zacks Investment Research • 08/02/24
Gilead Sciences (GILD) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research • 08/01/24
Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 3% Dividend YieldsBenzinga • 07/29/24
Gilead Sciences to Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024Business Wire • 07/25/24